73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study refines understanding of T cells' action in HIV immune response

Study refines understanding of T cells' action in HIV immune response

by Los Alamos National LaboratoryThe effect of M-T807R1 administration and RAL monotherapy on blood CD8+T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual m

Study refines understanding of T cells' action in HIV immune response

by Los Alamos National LaboratoryThe effect of M-T807R1 administration and RAL monotherapy on blood CD8+T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual m
Study shows breast cancer overdiagnosis common among older women

Study shows breast cancer overdiagnosis common among older women

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA study of more than 50,000 women found that continued breast cancer screening after age 70 was associated with a greater inciden

Study shows breast cancer overdiagnosis common among older women

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA study of more than 50,000 women found that continued breast cancer screening after age 70 was associated with a greater inciden
Eliminating extra chromosomes in cancer cells prevents tumor growth, new study reveals

Eliminating extra chromosomes in cancer cells prevents tumor growth, new study reveals

by Yale UniversityCredit: Pixabay/CC0 Public DomainCancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the ce

Eliminating extra chromosomes in cancer cells prevents tumor growth, new study reveals

by Yale UniversityCredit: Pixabay/CC0 Public DomainCancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the ce
Researchers find a new promising therapeutic target for glioblastoma

Researchers find a new promising therapeutic target for glioblastoma

by Spanish National Research CouncilGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Glioblastoma is the most frequent and aggre

Researchers find a new promising therapeutic target for glioblastoma

by Spanish National Research CouncilGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Glioblastoma is the most frequent and aggre
Neutralizing the side effects of epidermal growth factor inhibitor drugs

Neutralizing the side effects of epidermal growth factor inhibitor drugs

by Justin Jackson , Medical XpressIdentifying compounds that block anti-EGFR monoclonal antibodies binding to EGFR. (A) Illustration of the process used to identify lead compounds. "Hit" mol

Neutralizing the side effects of epidermal growth factor inhibitor drugs

by Justin Jackson , Medical XpressIdentifying compounds that block anti-EGFR monoclonal antibodies binding to EGFR. (A) Illustration of the process used to identify lead compounds. "Hit" mol
Study reveals insights into how cancer cells evade treatment

Study reveals insights into how cancer cells evade treatment

by Addison Dehaven,South Dakota State UniversityCancers use sugar residues to engage in multidrug resistance. The research conducted by the RAWC Lab reveals breakthrough insights into exactly ho

Study reveals insights into how cancer cells evade treatment

by Addison Dehaven,South Dakota State UniversityCancers use sugar residues to engage in multidrug resistance. The research conducted by the RAWC Lab reveals breakthrough insights into exactly ho
Discovery of a gene that could be key for reducing breast cancer risk

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu
Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

by Brandon Chase,Massachusetts General HospitalA molecule called MHC-II (seen here in green) disguises metastatic breast cancer cells (red), allowing them to invade the lymph nodes and take root

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

by Brandon Chase,Massachusetts General HospitalA molecule called MHC-II (seen here in green) disguises metastatic breast cancer cells (red), allowing them to invade the lymph nodes and take root
Overall, drinking wine does not impact prostate cancer risk

Overall, drinking wine does not impact prostate cancer risk

(HealthDay)—Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 inClinical Epidemiology.Mihai Dorin Vartolomei, Ph.D.,

Overall, drinking wine does not impact prostate cancer risk

(HealthDay)—Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 inClinical Epidemiology.Mihai Dorin Vartolomei, Ph.D.,
Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more
Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich
Research uncovers alternate mechanism for producing key protein in metastatic prostate cancer

Research uncovers alternate mechanism for producing key protein in metastatic prostate cancer

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainLike the better-known prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA) is a biomarker that can tell physi

Research uncovers alternate mechanism for producing key protein in metastatic prostate cancer

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainLike the better-known prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA) is a biomarker that can tell physi